Chicos FAS Inc (CHS) Fundamental Analysis & Valuation

NYSE:CHS • US1686151028

Current stock price

7.59 USD
-0.01 (-0.13%)
At close:
7.591 USD
+0 (+0.01%)
After Hours:

This CHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CHS Profitability Analysis

1.1 Basic Checks

  • In the past year CHS was profitable.
  • In the past year CHS had a positive cash flow from operations.
  • In multiple years CHS reported negative net income over the last 5 years.
  • Of the past 5 years CHS 4 years had a positive operating cash flow.
CHS Yearly Net Income VS EBIT VS OCF VS FCFCHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.82%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 26.40%, CHS is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
  • CHS has a better Return On Invested Capital (12.31%) than 77.52% of its industry peers.
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROIC 12.31%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
CHS Yearly ROA, ROE, ROICCHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

  • CHS has a better Profit Margin (5.29%) than 72.87% of its industry peers.
  • CHS's Profit Margin has improved in the last couple of years.
  • CHS has a better Operating Margin (6.16%) than 68.22% of its industry peers.
  • In the last couple of years the Operating Margin of CHS has grown nicely.
  • CHS's Gross Margin of 38.94% is in line compared to the rest of the industry. CHS outperforms 59.69% of its industry peers.
  • In the last couple of years the Gross Margin of CHS has remained more or less at the same level.
Industry RankSector Rank
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
CHS Yearly Profit, Operating, Gross MarginsCHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CHS Health Analysis

2.1 Basic Checks

  • CHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CHS has more shares outstanding than it did 1 year ago.
  • CHS has a better debt/assets ratio than last year.
CHS Yearly Shares OutstandingCHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CHS Yearly Total Debt VS Total AssetsCHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

  • CHS has an Altman-Z score of 3.22. This indicates that CHS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.22, CHS is in the better half of the industry, outperforming 70.54% of the companies in the same industry.
  • The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.42, CHS belongs to the best of the industry, outperforming 82.17% of the companies in the same industry.
  • A Debt/Equity ratio of 0.06 indicates that CHS is not too dependend on debt financing.
  • CHS has a Debt to Equity ratio of 0.06. This is in the better half of the industry: CHS outperforms 75.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Altman-Z 3.22
ROIC/WACC1.34
WACC9.19%
CHS Yearly LT Debt VS Equity VS FCFCHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

  • CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.20, CHS is doing worse than 72.09% of the companies in the same industry.
  • CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.42, CHS is doing worse than 60.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.42
CHS Yearly Current Assets VS Current LiabilitesCHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CHS Growth Analysis

3.1 Past

  • The earnings per share for CHS have decreased strongly by -15.38% in the last year.
  • Measured over the past 5 years, CHS shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
  • CHS shows a decrease in Revenue. In the last year, the revenue decreased by -0.24%.
  • Measured over the past years, CHS shows a decrease in Revenue. The Revenue has been decreasing by -1.26% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%

3.2 Future

  • The Earnings Per Share is expected to decrease by -8.47% on average over the next years.
  • Based on estimates for the next years, CHS will show a small growth in Revenue. The Revenue will grow by 0.60% on average per year.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHS Yearly Revenue VS EstimatesCHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
CHS Yearly EPS VS EstimatesCHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

6

4. CHS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.86, the valuation of CHS can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHS indicates a somewhat cheap valuation: CHS is cheaper than 79.07% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, CHS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 10.29, the valuation of CHS can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CHS indicates a somewhat cheap valuation: CHS is cheaper than 74.42% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CHS to the average of the S&P500 Index (21.99), we can say CHS is valued rather cheaply.
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
CHS Price Earnings VS Forward Price EarningsCHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHS indicates a rather cheap valuation: CHS is cheaper than 85.27% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHS indicates a somewhat cheap valuation: CHS is cheaper than 67.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.37
EV/EBITDA 4.72
CHS Per share dataCHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The decent profitability rating of CHS may justify a higher PE ratio.
  • A cheap valuation may be justified as CHS's earnings are expected to decrease with -8.47% in the coming years.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CHS Dividend Analysis

5.1 Amount

  • No dividends for CHS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CHS Fundamentals: All Metrics, Ratios and Statistics

Chicos FAS Inc

NYSE:CHS (1/4/2024, 8:04:00 PM)

After market: 7.591 +0 (+0.01%)

7.59

-0.01 (-0.13%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-30
Earnings (Next)N/A
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Revenue(TTM)2.11B
Net Income(TTM)111.58M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 9.86
Fwd PE 10.29
P/S 0.44
P/FCF 16.37
P/OCF 8.25
P/B 2.22
P/tB 2.34
EV/EBITDA 4.72
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.4%
ROCE 15.79%
ROIC 12.31%
ROICexc 14.55%
ROICexgc 15.01%
OM 6.16%
PM (TTM) 5.29%
GM 38.94%
FCFM 2.71%
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.42
Debt/EBITDA 0.14
Cap/Depr 134.65%
Cap/Sales 2.67%
Interest Coverage 35.98
Cash Conversion 66.14%
Profit Quality 51.32%
Current Ratio 1.2
Quick Ratio 0.42
Altman-Z 3.22
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%

Chicos FAS Inc / CHS Fundamental Analysis FAQ

What is the fundamental rating for CHS stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHS.


What is the valuation status of Chicos FAS Inc (CHS) stock?

ChartMill assigns a valuation rating of 6 / 10 to Chicos FAS Inc (CHS). This can be considered as Fairly Valued.


How profitable is Chicos FAS Inc (CHS) stock?

Chicos FAS Inc (CHS) has a profitability rating of 6 / 10.


What is the financial health of Chicos FAS Inc (CHS) stock?

The financial health rating of Chicos FAS Inc (CHS) is 6 / 10.


How sustainable is the dividend of Chicos FAS Inc (CHS) stock?

The dividend rating of Chicos FAS Inc (CHS) is 0 / 10 and the dividend payout ratio is 0%.